Rankings
▼
Calendar
AQST Q4 2017 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$427M
Q4 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$12M
Gross Profit
$7M
54.0% margin
Operating Income
-$7M
-59.5% margin
Net Income
-$10M
-82.3% margin
EPS (Diluted)
$-0.50
QoQ Revenue Growth
-55.1%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$43M
Total Liabilities
$70M
Stockholders' Equity
-$26M
Cash & Equivalents
$17M
← FY 2017
All Quarters
Q1 2018 →
